You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adult acute lymphoblastic leukemia in remission

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Determining the Mechanisms of Loss of CAR T Cell Persistence

Not yet recruiting
  • Acute Lymphoblastic Leukemia With Failed Remission
  • +4 more
    • (no location specified)
    Mar 29, 2023

    DNA Samples From Acute Lymphoblastic Leukemia or Acute Myeloid

    Completed
    • Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
    • +8 more
    • Laboratory Biomarker Analysis
    • Philadelphia, Pennsylvania
      Childrens Oncology Group
    Jul 12, 2022

    Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +5 more
    • CD19 specific Chimeric Antigen Receptor T Cell
    • Columbus, Ohio
      Nationwide Children's Hospital
    Mar 9, 2023

    Survival in Adult MRD Positive Acute Lymphoblastic Leukemia

    Completed
    • Acute Lymphoblastic Leukemia
      • Brno, Czechia
      • +9 more
      Sep 12, 2022

      Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia

      Recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • +5 more
      • CAR-20/19-T cells (1 x 10^5 CAR-20/19-T cells/kg)
      • +4 more
      • Milwaukee, Wisconsin
        Medical College of Wisconsin
      Sep 22, 2022

      Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

      Active, not recruiting
      • Adult Acute Lymphoblastic Leukemia in Remission
      • +14 more
      • radiation therapy
      • +8 more
      • Columbus, Ohio
        Arthur G. James Cancer Hospital and Solove Research Institute at
      Oct 7, 2022

      Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

      Terminated
      Has Results
      • Acute Biphenotypic Leukemia
      • +29 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 4, 2023

      Acute Lymphoid Leukemia, Acute Lymphoblastic Leukemia Trial in Aurora (CD19 Directed CAR T Cell)

      Not yet recruiting
      • Acute Lymphoid Leukemia
      • Acute Lymphoblastic Leukemia
      • CD19 Directed CAR T Cell
      • Aurora, Colorado
        University of Colorado Hospital
      Sep 12, 2022

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute

      Active, not recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +13 more
      • CMVpp65-A*0201 peptide vaccine
      • +2 more
      • Duarte, California
      • +4 more
      Jan 4, 2023

      Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)

      Not yet recruiting
      • Acute Lymphoblastic Leukemia in Remission
      • +10 more
      • CliniMACS
      • Houston, Texas
      • +1 more
      Dec 8, 2022

      Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult

      Active, not recruiting
      • Adult Acute Lymphoblastic Leukemia in Remission
      • +6 more
      • Duarte, California
        City of Hope Medical Center
      Feb 17, 2022

      B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

      Not yet recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • HY004
      • +2 more
      • (no location specified)
      Aug 18, 2023

      Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)

      Recruiting
      • Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
      • Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Dec 13, 2022

      B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

      Not yet recruiting
      • B Acute Lymphoblastic Leukemia
      • +2 more
      • Azacitidine Injection
      • +2 more
      • (no location specified)
      Oct 15, 2023

      Acute Lymphoblastic Leukemia in Remission, Cancer Survivors Trial in Duarte, Philadelphia (Nicotinamide Riboside, Placebo,

      Recruiting
      • Acute Lymphoblastic Leukemia in Remission
      • Cancer Survivors
      • Nicotinamide Riboside
      • +2 more
      • Duarte, California
      • +1 more
      Jun 21, 2022

      Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

      Completed
      Has Results
      • Accelerated Phase Chronic Myelogenous Leukemia
      • +23 more
      • Denver, Colorado
      • +2 more
      Jun 17, 2021

      Adult Acute Myeloid Leukemia in Remission, Acute Biphenotypic Leukemia, Early Relapse of Acute Myeloid Leukemia Trial in Duarte

      Active, not recruiting
      • Adult Acute Myeloid Leukemia in Remission
      • +12 more
      • Duarte, California
        City of Hope Medical Center
      Feb 17, 2022

      Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)

      Not yet recruiting
      • Acute Lymphoblastic Leukemia, in Relapse
      • Acute Lymphoblastic Leukemia With Failed Remission
      • São Paulo, SP, Brazil
        Instituto do Cancer do Estado de Sao Paulo
      Sep 12, 2023

      Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

      Active, not recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia
      • +125 more
      • tetanus-CMV fusion peptide vaccine
      • laboratory biomarker analysis
      • Duarte, California
        City of Hope Medical Center
      Feb 28, 2022

      T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)

      Terminated
      • T-Acute Lymphoblastic Leukemia
      • Adult T Lymphoblastic Lymphoma
      • Saint Louis, Missouri
      • +1 more
      Jan 18, 2023

      Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult Trial in Zhuhai (Thiotepa,

      Recruiting
      • Burkitt Lymphoma
      • +2 more
      • Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen
      • Zhuhai, Guangdong, China
        The Fifth Affiliated Hospital of Sun Yat-sen University
      Sep 25, 2023

      B-All, Acute Lymphoblastic Leukemia Trial run by the National Cancer Institute (NCI) (NGS testing)

      Not yet recruiting
      • B-All
      • Acute Lymphoblastic Leukemia
      • NGS testing
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult

      Terminated
      • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
      • +9 more
      • Allogeneic Bone Marrow Transplantation
      • +7 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Oct 4, 2021

      Acute Lymphoblastic Leukemia Trial in Ann Arbor (Dasatinib, Ponatinib, Berlin-Frankfurt-Münster Chemotherapy)

      Recruiting
      • Acute Lymphoblastic Leukemia
      • Ann Arbor, Michigan
        University of Michigan Rogel Cancer Center
      Nov 28, 2022

      B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

      Recruiting
      • B-Cell Lymphoblastic Leukemia
      • Acute Lymphoblastic Leukemia
      • Tampa, Florida
        Moffitt Cancer Center
      Nov 28, 2023